Dr. Michael Ho, MD, PhD
Claim this profileUniversity of Colorado Denver
Studies Cardiovascular Disease
Studies Sleep Apnea and Cardiovascular Disease
3 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Michael Ho, MD, PhD is currently running
AI Text Messaging
for Cardiovascular Disease
The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot messages with proactive pharmacist support. To measure cardiovascular risk factors, the investigators are using the American Heart Association's Life's Essential 8 (LE8) factors-blood glucose, cholesterol, blood pressure, physical activity, body mass index, diet, and smoking. This study focuses on improving cardiovascular risk factors for individuals facing health disparities, such as ethnic minorities, limited English proficiency, and low-income groups. These groups are more likely to be seriously affected by cardiovascular diseases. Self-management, or an individual's roles in managing their own chronic disease, includes lifestyle changes, medication adherence. Improving patients' self-management has been shown to improve health behaviors, better disease control and improved patient outcomes. The main question this study aims to answer is if one of the strategies (texting, chatbot, or chatbot with pharmacist support) may improve patient self-management and patient outcomes. The investigators will enroll up to 2,100 patients from three health systems that serve large populations experiencing health disparities: Denver Health, Salud Family Health Centers, and STRIDE Community Health Center. The results might help researchers and health care systems find the best ways to involve patients with health disparities to managing their chronic cardiovascular disease.
Recruiting1 award N/A
Telehealth-Based Walking Program
for Peripheral Arterial Disease
Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, information on healthy walking and motivational messages. The two delivery methods include a web-based delivery and an telehealth delivery. Participants are randomized to either one of the delivery methods or usual care. After 12 weeks participants in the web based or telehealth based groups maybe re-randomized to receive a combination of both web-based and telehealth for a second 12 week period. After 24 weeks, everyone is followed for an additional 12 weeks, so the total time a participant is in the study is 36 weeks. At baseline, 12, 24 and 36 weeks the investigators ask participant to walk (slowly) on a treadmill, perform a six-minute walk test, and several questionnaires on quality of life. Vouchers are provided at each study visit. All participants who complete the study also keep their pedometer.
Recruiting1 award N/A8 criteria
More about Michael Ho, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael Ho, MD, PhD has experience with
- AI Text Messaging
- Nudge
- Walking Program
Breakdown of trials Michael Ho, MD, PhD has run
Cardiovascular Disease
Sleep Apnea and Cardiovascular Disease
Lifestyle Factors
Coronary Artery Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Ho, MD, PhD specialize in?
Michael Ho, MD, PhD focuses on Cardiovascular Disease and Sleep Apnea and Cardiovascular Disease. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is Michael Ho, MD, PhD currently recruiting for clinical trials?
Yes, Michael Ho, MD, PhD is currently recruiting for 2 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Michael Ho, MD, PhD has studied deeply?
Yes, Michael Ho, MD, PhD has studied treatments such as AI Text Messaging, Nudge, Walking Program.
What is the best way to schedule an appointment with Michael Ho, MD, PhD?
Apply for one of the trials that Michael Ho, MD, PhD is conducting.
What is the office address of Michael Ho, MD, PhD?
The office of Michael Ho, MD, PhD is located at: University of Colorado Denver, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Denver.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.